Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

Treatment options and risk stratification for esophageal adenocarcinomas (EAC) currently rely on pathological criteria such as tumor staging. However, with advancement in immune modulated treatments, there is a need for accurate predictive biomarkers that will help identify high-risk patients and pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Babar, Laila, Kosovec, Juliann E., Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N., Salvitti, Madison S., Smith, Matthew A., Goel, Ajay, Kelly, Ronan J., Jobe, Blair A., Zaidi, Ali H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642049/
https://www.ncbi.nlm.nih.gov/pubmed/31360303
http://dx.doi.org/10.18632/oncotarget.27052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642049/
https://www.ncbi.nlm.nih.gov/pubmed/31360303
http://dx.doi.org/10.18632/oncotarget.27052

Ejemplares similares